U.S. National Institutes of Health
U.S. National Institutes of Health

IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4449144491Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)Active, not recruitingNo Results AvailableConstipationDrug: SP-333 1 mg|Drug: SP-333 3 mg|Drug: SP-333 6 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01983306
4449244492CRT Implant Strategy Using the Longest Electrical Delay for Non-left Bundle Branch Block PatientsEnrolling by invitationNo Results AvailableNon-left Bundle Branch Block|Ischemic or Non-ischemic CardiomyopathyOther: QLV based implant strategy|Other: Standard of care implant strategyhttps://ClinicalTrials.gov/show/NCT01983293
4449344493The Effect of Healing Touch on Sleep Patterns of Pediatric Burn PatientsCompletedNo Results AvailableBurnOther: Healing Touchhttps://ClinicalTrials.gov/show/NCT01983280
4449444494Evaluation Prospectively the Level of Reduction in Cognitive Functions of Cancer Patients Who Are on Active Oncology Treatments and Use Cannabis. The Second Goal is to Identify High-risk Groups for Cognitive Impairment Due to Cannabis Use.RecruitingNo Results Available1- Cancer Patients During Chemotherapy Treatment|2- Use of Cannabis Comparing to Control Without Cannabis UseDrug: cannabishttps://ClinicalTrials.gov/show/NCT01983267
4449544495Improving Psychological Distress Among Critical Illness Survivors and Their CaregiversActive, not recruitingNo Results AvailableIntensive Care Unit Survivors|Informal Caregivers (Family and Friends)Behavioral: coping skills training|Other: education programhttps://ClinicalTrials.gov/show/NCT01983254
4449644496Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)RecruitingNo Results AvailablePulmonary Emphysema in Alpha-1 PI DeficiencyBiological: Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP)|Other: 0.9% Sodium Chloride for Injection, USPhttps://ClinicalTrials.gov/show/NCT01983241
4449744497A Proactive Walking Trial to Reduce Pain in Black VeteransNot yet recruitingNo Results AvailableMusculoskeletal PainBehavioral: Intervention Conditionhttps://ClinicalTrials.gov/show/NCT01983228
4449844498Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin SitesEnrolling by invitationNo Results AvailableObesity|Diabetes|Peripheral Vascular DiseaseDevice: Prevena vachttps://ClinicalTrials.gov/show/NCT01983215
4449944499Obstetric Outcomes in Women With PCOSCompletedNo Results AvailablePolycystic Ovary Syndrome, PCOShttps://ClinicalTrials.gov/show/NCT01983202
4450044500Transcranial Magnetic Stimulation for Evaluation and Treatment of Repetetive Behaviors in AutismTerminatedNo Results AvailableAutism|Asperger Disorder|Other Developmental Pervasive Disorder.Procedure: transcranial magnetic stimulationhttps://ClinicalTrials.gov/show/NCT01983189
4450144501Retrospective Clinical Outcome of Parotid Tumor SurgeryCompletedNo Results AvailableParotid Tumors|Postoperative Complicationshttps://ClinicalTrials.gov/show/NCT01983176
4450244502Efficacy of Modified Atkins Diet Versus Ketogenic Diet in Children With Refractory Epilepsy Aged 1 Year to 18 Years: A Randomized Controlled TrialRecruitingNo Results AvailableKetogenic Diet, Modified Atkin's Diet, Refractory EpilepsyOther: Ketogenic diet (2.5 to 4:1)|Other: Modified Atkin's diethttps://ClinicalTrials.gov/show/NCT01983163
4450344503A Randomized Controlled Trial to Test the Effect of a Smartphone Quit Smoking Intervention on Young Adult SmokersRecruitingNo Results AvailableCigarette SmokingBehavioral: Crush the Crave Application|Behavioral: On the Road to Quitting - Self Helphttps://ClinicalTrials.gov/show/NCT01983150
4450444504A Non-interventional, Observational Study for Targinact® Treatment in Patients With Severe Pain.CompletedNo Results AvailableSevere PainDrug: Targinact® (oxycodone/naloxone)https://ClinicalTrials.gov/show/NCT01983137
4450544505Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on VemurafenibActive, not recruitingNo Results AvailableMalignant Melanoma Stage IVDrug: Fotemustine + Vemurafenibhttps://ClinicalTrials.gov/show/NCT01983124
4450644506Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)CompletedNo Results AvailablePainDrug: buprenorphine, tramadol/acetaminophenhttps://ClinicalTrials.gov/show/NCT01983111
4450744507Analysis of Circulating Tumor DNA to Monitor Metastatic Colorectal Cancer TreatmentRecruitingNo Results AvailableTo Compare the Monitoring of Circulating Tumor DNA With the Efficacy of Chemotherapy Evaluated by Computer Tomography Scan.https://ClinicalTrials.gov/show/NCT01983098
4450844508Nitric Oxide Generating Gel Dressing in Patients With Superficial Partial Thickness WoundsActive, not recruitingNo Results AvailableSuperficial Partial Thickness Burn|Skin Graft; ComplicationsDevice: NOx dressing|Device: Standard of Carehttps://ClinicalTrials.gov/show/NCT01983085
4450944509Symbiotic & ColonizationCompletedNo Results AvailableHealthyDietary Supplement: Infant formula|Other: Breastfeedinghttps://ClinicalTrials.gov/show/NCT01983072
4451044510Swiss Liver Venous Thrombosis StudyRecruitingNo Results AvailableObservational Studyhttps://ClinicalTrials.gov/show/NCT01983059
4451144511Rectal Short Chain Fatty Acids Combinations and Substrate and Energy MetabolismCompletedNo Results AvailableObesity|Type 2 DiabetesDrug: Three different mixture of acetate, butyrate and propionate and palcebohttps://ClinicalTrials.gov/show/NCT01983046
4451244512Training Protocol 'Drop it'. The Impact of a Training Protocol Focused on Coping With Negative Repetitive Thinking on Cognitive and Behavioural Functioning of People Suffering From GAD or Minor or Moderate Depressive Disorder or Depressive Disorder in RemRecruitingNo Results AvailableRepetitive Negative Thinking|Generalized Anxiety Disorder|Mild or Moderate Depressive Disorder|Depression in Remission.Behavioral: Drop It training session|Behavioral: treatment as usualhttps://ClinicalTrials.gov/show/NCT01983033
4451344513Peri-Operative Lidocane, Ketamine, or Lidocane and Ketamine Combination, Infusion for Patients Undergoing Spine SurgeryCompletedNo Results AvailablePostoperative PainDrug: Lidocaine|Drug: Ketaminehttps://ClinicalTrials.gov/show/NCT01983020
4451444514Effect of Physical Exercise on Endothelial Function in Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes MellitusProcedure: High-intensity exercise|Procedure: Low-intensity exercisehttps://ClinicalTrials.gov/show/NCT01983007
4451544515Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical PatientsRecruitingNo Results AvailableGastrointestinal NeoplasmsBehavioral: Education/Daily Planninghttps://ClinicalTrials.gov/show/NCT01982994
4451644516Instrument Design and Validation to Asses the Perception of Wellbeing Associated to Plain Water.CompletedNo Results AvailableWellbeingOther: water provision|Other: Water provisionhttps://ClinicalTrials.gov/show/NCT01982981
4451744517Treatment of IPF With Laparoscopic Anti-Reflux SurgeryRecruitingNo Results AvailableIdiopathic Pulmonary Fibrosis|Gastroesophageal RefluxProcedure: Surgeryhttps://ClinicalTrials.gov/show/NCT01982968
4451844518MSC2156119J With Gefitinib in Subjects With Advanced Non-small Cell Lung CancerRecruitingNo Results AvailableNon-small Cell Lung CancerDrug: MSC2156119J|Drug: Gefitinib|Drug: Pemetrexed|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT01982955
4451944519Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisActive, not recruitingNo Results AvailableMultiple Sclerosis, Primary Progressive|Multiple Sclerosis, Secondary ProgressiveDrug: ibudilast|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01982942
4452044520An Evaluation of Post Caesarean-Section Pain Control Regimens: Non-Opioid Oral Regimen With and Without Transversus Abdominis Plane BlockNot yet recruitingNo Results AvailableReduction in Post Ceasarean-section Related Pain in Study Group (TAP Block)Procedure: TAP block (Bupivacaine 0.25% with epinephrine 1:400,000 50 cc), & Oral Meds: Paracetamol 1000 mg PO Q8H, diclofenac 50 mg PO Q8H X 24 hours.https://ClinicalTrials.gov/show/NCT01982929

* Görseller ve İçerik tekif hakkına sahip olabilir